Clinical Case Scenarios in HR-Positive, HER2-Negative Early Breast Cancer: Assess the Risk of Recurrence and Eligibility for Adjuvant Therapy Authors: Seth Wander, MD, PhD; Manali Bhave, MD

https://www.medscape.org/viewarticle/1002194_sidebar8?sso=true&uac=148436CN&ecd=mkm_ret_250621_mscpmrk-ES_CME_etid7505456&impID=7505456